Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 1, 2011, Pages 50-54

  Sun, Fu Rong ^a   Wang, Ying ^a   Wang, Bing Yuan ^a   Tong, Jing ^a   Zhang, Dai ^a   Chang, Bing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Left ventricular dysfunction; Liver cirrhosis; Liver disease; Model for end stage liver disease score

Indexed keywords

CREATININE;

ADULT; AORTA FLOW; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; BLOOD CLOTTING; CREATININE BLOOD LEVEL; DIGESTIVE SYSTEM EXAMINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; END STAGE LIVER DISEASE; FEMALE; GASTROINTESTINAL TRACT; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; ORTHOTOPIC TRANSPLANTATION; PREOPERATIVE EVALUATION; QT INTERVAL; SCORING SYSTEM; VIROLOGY;

EID: 79952044583     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60007-6     Document Type: Article

References (24)

1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025-1033.
2. Abelmann WH, Kowalski HJ, McNeely WF. The hemodynamic response to exercise in patients with Laennec's cirrhosis. J Clin Invest 1955;34:690-695.
3. van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol 1996;24:747-752. (Pubitemid 26226672)
4. Piscaglia F, Valgimigli M, Rapezzi C, Ferlito M, Gaiani S, Siringo S, et al. Left ventricular volumes in liver cirrhosis. Dig Liver Dis 2000;32:392-397. (Pubitemid 30612335)
5. Gaskari SA, Honar H, Lee SS. Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 2006; 3:329-337. (Pubitemid 43842249)
6. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451-459. (Pubitemid 26260046)
7. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002;26:842-847. (Pubitemid 35334245)
8. Møller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002;87:9-15. (Pubitemid 34074942)
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
10. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470. (Pubitemid 32119037)
11. Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol 2006;12:837-842.
12. Wong JL, Arango-Viana JC, Squires T. Heart, liver and spleen pathology in chronic alcohol and drug users. J Forensic Leg Med 2008;15:141-147. (Pubitemid 351292348)
13. Pozzi M, Redaelli E, Ratti L, Poli G, Guidi C, Milanese M, et al. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol 2005;51:179-186. (Pubitemid 44251909)
14. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95:3200-3205.
15. De Marco M, Chinali M, Romano C, Benincasa M, D'Addeo G, D'Agostino L, et al. Increased left ventricular mass in preliver transplantation cirrhotic patients. J Cardiovasc Med (Hagerstown) 2008;9:142-146.
16. Woo JJ, Koh YY, Kim HJ, Chung JW, Chang KS, Hong SP. N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients. Yonsei Med J 2008;49:625-631.
17. Alexander J, Mishra P, Desai N, Ambadekar S, Gala B, Sawant P. Cirrhotic cardiomyopathy: Indian scenario. J Gastroenterol Hepatol 2007;22:395-399. (Pubitemid 46238771)
18. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 2001;49:268-275. (Pubitemid 32675122)
19. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis 2007;39:507-515. (Pubitemid 46746640)
20. Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, et al. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond) 2009;116:851-859.
21. Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int 2003;23:243-248. (Pubitemid 37265799)
22. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009;104:2458-2466.
23. Salvetti M, Muiesan ML, Paini A, Monteduro C, Bonzi B, Galbassini G, et al. Myocardial ultrasound tissue characterization in patients with chronic renal failure. J Am Soc Nephrol 2007;18:1953-1958. (Pubitemid 46870333)
24. Ripoll C, Catalina MV, Yotti R, Olmedilla L, Pérez-Peña J, Lo Iacono O, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008;85:1766-1772.